Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A lethal form of ASCC3 disease: severe global developmental delay, axial hypotonia, hypoplasia of corpus callosum, hypothyroidism and micropenis.

HGG advances·2026
Same author

FACS-based dual fluorescence reporter assay demonstrates efficacy of antisense oligonucleotide therapy of novel <i>PRPF3</i> intronic splice variant.

Molecular therapy. Nucleic acids·2026
Same author

A Novel Variant in an Israeli Bedouin Family: The First Reported Cases of Carbonic Anhydrase VA (CA5A) Deficiency in Israel.

Genes·2026
Same author

Effect of cumulative blood pressure exposure on long-term cardiovascular outcomes in the community, a nationwide cohort study.

The American journal of medicine·2026
Same author

Reversal of Severe Left Ventricular Dysfunction Following Kidney Transplantation: A Case Report.

The Israel Medical Association journal : IMAJ·2026
Same author

The Genetic Landscape of Inherited Retinal Diseases in the Israeli Population.

Investigative ophthalmology & visual science·2026
Same journal

Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease.

The Canadian journal of cardiology·2026
Same journal

Storm Clouds Coming: Red-Flag Warning for Hypertension Prevalence and Control in the Post-COVID-19 Era.

The Canadian journal of cardiology·2026
Same journal

Universal coverage, unequal care: Why Canada needs a national cardiovascular access ledger.

The Canadian journal of cardiology·2026
Same journal

Prolonged Loop Recorder Retention: Safety, Diagnostic Yield, and the Case for Community-Based Explantation.

The Canadian journal of cardiology·2026
Same journal

Multimodality Fusion Imaging of Subclinical Systemic Right Ventricular Remodeling in Congenitally Corrected Transposition of the Great Arteries.

The Canadian journal of cardiology·2026
Same journal

Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-Analysis of Randomized Controlled Trials.

The Canadian journal of cardiology·2026
See all related articles

Related Experiment Video

Updated: May 30, 2025

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

6.9K

Mitral Valve Prolapse Caused by TLL1 Gain-of-Function Mutation.

Nadav Agam1, Vadim Dolgin1, Artyom Star2

  • 1The Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences and National Institute of Biotechnology in the Negev, Ben Gurion University of the Negev, Be'er Sheva, Israel.

The Canadian Journal of Cardiology
|January 29, 2025
PubMed
Summary
This summary is machine-generated.

A novel gain-of-function mutation in the TLL1 gene causes autosomal dominant mitral valve prolapse (MVP). This discovery offers new insights into valvular disease and TLL1

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

15.9K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.6K

Related Experiment Videos

Last Updated: May 30, 2025

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

6.9K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

15.9K
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

9.6K

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Mitral valve prolapse (MVP) is a common heart condition.
  • Genetic mutations in various pathways can cause MVP.
  • A family with three generations exhibiting dominant isolated MVP was studied.

Purpose of the Study:

  • To identify the genetic cause of isolated mitral valve prolapse (MVP) in a multi-generational family.
  • To investigate the functional consequences of identified genetic variants.
  • To understand the role of TLL1 in valvular disease.

Main Methods:

  • Clinical evaluation and echocardiography of 13 family members.
  • Whole exome and genome sequencing to identify variants.
  • Sanger sequencing for variant segregation analysis.
  • Enzymatic activity assays of Tolloid-like 1 (TLL1) in transfected cells.

Main Results:

  • A heterozygous p.T253A variant in the TLL1 gene segregated with MVP in the family.
  • The TLL1 variant showed a 3.4-fold increase in enzymatic activity compared to wild-type.
  • 6 out of 8 heterozygotes presented with MVP or trivial mitral regurgitation.

Conclusions:

  • A TLL1 gain-of-function mutation causes autosomal dominant MVP with variable expressivity.
  • This mutation prolongs the half-life of active TLL1 protein in the extracellular matrix.
  • Findings provide novel insights into TLL1's role in valvular physiology, development, and disease.